1 results match your criteria: "Saint Bartholomew's Hospital and the Royal London School of Medicine and Dentistry[Affiliation]"
The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan.
Cancer Res
May 1997
Department of Experimental Pathology, Saint Bartholomew's Hospital and the Royal London School of Medicine and Dentistry, United Kingdom.
Topical diclofenac in 2.5% hyaluronan inhibits basal cell carcinoma, actinic keratosis, and murine colon-26 growth in vivo. colon-26 tumor growth was preceded by angiogenesis and reduced apoptotic and mitotic indices.
View Article and Find Full Text PDF